A pediatric phase II trial- SMHOP-metro01- set in collaboration between the Société Marocaine d’Hématologie et Oncologie Pédiatrique and the Metronomic Global Health Initiative, for children with advanced or relapse disease has been launched in Morocco. The study will be piloted by Pr. Maria El Kababri with the support of Pr Laila Hessissen, and Pr Mhamed Harif. The study is supported by the Fondation Lalla Salma and Gauthier Bouche from the AntiCancer Fund (previously Reliable Therapies) (...)